US 12,239,639 B2
Cytotoxic actin-targeting compounds
Rebecca Grange, Kingston (CA); John Allingham, Kingston (CA); Andrew Craig, Kingston (CA); P. Andrew Evans, Kingston (CA); and Madhu Aeluri, Kingston (CA)
Assigned to Queen's University at Kingston, Kingston (CA)
Filed by Queen's University at Kingston, Kingston (CA)
Filed on Jun. 27, 2022, as Appl. No. 17/849,949.
Application 17/849,949 is a continuation of application No. 16/639,207, granted, now 11,369,594, previously published as PCT/CA2018/051000, filed on Aug. 17, 2018.
Claims priority of provisional application 62/547,254, filed on Aug. 18, 2017.
Prior Publication US 2023/0037322 A1, Feb. 9, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/45 (2006.01); A61K 31/221 (2006.01); A61K 31/25 (2006.01); A61K 31/341 (2006.01); A61K 31/397 (2006.01); A61K 31/4015 (2006.01); A61K 45/06 (2006.01); A61K 47/36 (2006.01); C07C 235/28 (2006.01); C07C 321/10 (2006.01); C07D 205/08 (2006.01); C07D 207/27 (2006.01); C07D 211/76 (2006.01); C07D 307/46 (2006.01)
CPC A61K 31/45 (2013.01) [A61K 31/221 (2013.01); A61K 31/25 (2013.01); A61K 31/341 (2013.01); A61K 31/397 (2013.01); A61K 31/4015 (2013.01); A61K 45/06 (2013.01); A61K 47/36 (2013.01); C07C 235/28 (2013.01); C07C 321/10 (2013.01); C07D 205/08 (2013.01); C07D 207/27 (2013.01); C07D 211/76 (2013.01); C07D 307/46 (2013.01)] 15 Claims
 
1. A compound MA-02-058

OG Complex Work Unit Chemistry